These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33890177)

  • 1. Decreased expression of programmed death-1 on CD8
    Shan Y; Kong Y; Zhou Y; Guo J; Shi Q; Li S; Guo H; Huang Y; Ding S; Liu C; Cao L; Huang Y; Fang C; Hu J
    Acta Diabetol; 2021 Sep; 58(9):1239-1249. PubMed ID: 33890177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes.
    Fazeli P; Talepoor AG; Faghih Z; Gholijani N; Ataollahi MR; Ali-Hassanzadeh M; Moravej H; Kalantar K
    Immun Inflamm Dis; 2022 Oct; 10(10):e715. PubMed ID: 36169248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B lymphocytes expressing high levels of PD-L1 are key regulators of diabetes development in non-obese diabetic mice.
    Chen K; Xue Q; Liu F; Liu L; Yu C; Bian G; Zhang K; Fang C; Song J; Ju G; Wang J
    Mol Immunol; 2019 Oct; 114():289-298. PubMed ID: 31419705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Programmed cell death-1, PD-1, is dysregulated in T cells from children with new onset type 1 diabetes.
    Granados HM; Draghi A; Tsurutani N; Wright K; Fernandez ML; Sylvester FA; Vella AT
    PLoS One; 2017; 12(9):e0183887. PubMed ID: 28877189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Autoimmune T-Cell Memory by Stem Cell Educator Therapy: Phase 1/2 Clinical Trial.
    Delgado E; Perez-Basterrechea M; Suarez-Alvarez B; Zhou H; Revuelta EM; Garcia-Gala JM; Perez S; Alvarez-Viejo M; Menendez E; Lopez-Larrea C; Tang R; Zhu Z; Hu W; Moss T; Guindi E; Otero J; Zhao Y
    EBioMedicine; 2015 Dec; 2(12):2024-36. PubMed ID: 26844283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced PD-1 expression on circulating follicular and conventional FOXP3
    Vecchione A; Di Fonte R; Gerosa J; Jofra T; Cicalese MP; Napoleone V; Ippolito E; Galvani G; Ragogna F; Stabilini A; Bianconi E; Grogan P; Bonura C; Bonfanti R; Frontino G; Nano R; Melzi R; De Pellegrin M; Laurenzi A; Meschi F; Barera G; Rigamonti A; Indirli R; Bosi E; Piemonti L; Aiuti A; Battaglia M; Fousteri G
    Clin Immunol; 2020 Feb; 211():108319. PubMed ID: 31794865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of Tim-1 and Tim-4 molecules in regulatory T cells in type 1 diabetes.
    Guo H; Shen Y; Kong YH; Li S; Jiang R; Liu C; Fang C; Hu J
    Endocrine; 2020 Apr; 68(1):64-70. PubMed ID: 31916216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable frequencies of peripheral T-lymphocyte subsets in the diabetes spectrum from type 1 diabetes through latent autoimmune diabetes in adults (LADA) to type 2 diabetes.
    Tan T; Xiang Y; Deng C; Cao C; Ren Z; Huang G; Zhou Z
    Front Immunol; 2022; 13():974864. PubMed ID: 36091068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PD-1 and PD-L1 Expression in Peripheral CD4/CD8+ T Cells Is Restored in the Partial Remission Phase in Type 1 Diabetes.
    Li X; Zhong T; Tang R; Wu C; Xie Y; Liu F; Zhou Z
    J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32236416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.
    Tian C; Ansari MJ; Paez-Cortez J; Bagley J; Godwin J; Donnarumma M; Sayegh MH; Iacomini J
    J Immunol; 2007 Nov; 179(10):6762-9. PubMed ID: 17982066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological characteristics of preproinsulin-specific CD8+ T cells in subjects with juvenile-onset and adult-onset type 1 diabetes: A 1-year follow-up study.
    Paul M; Badal D; Jacob N; Dayal D; Kumar R; Bhansali A; Bhadada SK; Sachdeva N
    Pediatr Diabetes; 2018 Feb; 19(1):68-79. PubMed ID: 28488272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD-1 pathway-mediated regulation of islet-specific CD4
    Martinov T; Spanier JA; Pauken KE; Fife BT
    Immunoendocrinology (Houst); 2016; 3():. PubMed ID: 27656680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive glia promote development of CD103
    Prasad S; Hu S; Sheng WS; Chauhan P; Lokensgard JR
    Immun Inflamm Dis; 2018 Jun; 6(2):332-344. PubMed ID: 29602245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated IFN-alpha/beta levels in a streptozotocin-induced type I diabetic mouse model promote oxidative stress and mediate depletion of spleen-homing CD8+ T cells by apoptosis through impaired CCL21/CCR7 axis and IL-7/CD127 signaling.
    Mahmoud MH; Badr G; Badr BM; Kassem AU; Mohamed MS
    Cell Signal; 2015 Oct; 27(10):2110-9. PubMed ID: 26192098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromal PD-L1-Positive Regulatory T cells and PD-1-Positive CD8-Positive T cells Define the Response of Different Subsets of Non-Small Cell Lung Cancer to PD-1/PD-L1 Blockade Immunotherapy.
    Wu SP; Liao RQ; Tu HY; Wang WJ; Dong ZY; Huang SM; Guo WB; Gou LY; Sun HW; Zhang Q; Xie Z; Yan LX; Su J; Yang JJ; Zhong WZ; Zhang XC; Wu YL
    J Thorac Oncol; 2018 Apr; 13(4):521-532. PubMed ID: 29269008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ CD122+ PD-1- effector cells promote the development of diabetes in NOD mice.
    Arndt B; Witkowski L; Ellwart J; Seissler J
    J Leukoc Biol; 2015 Jan; 97(1):111-20. PubMed ID: 25387835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PD-1-dependent restoration of self-tolerance in the NOD mouse model of diabetes after transient anti-TCRβ mAb therapy.
    Schroder PM; Khattar M; Baum CE; Miyahara Y; Chen W; Vyas R; Muralidharan S; Mierzejewska B; Stepkowski SM
    Diabetologia; 2015 Jun; 58(6):1309-18. PubMed ID: 25794782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequencies of CD8 and DN MAIT Cells Among Children Diagnosed With Type 1 Diabetes Are Similar to Age-Matched Controls.
    Harms RZ; Ostlund KR; Cabrera M; Edwards E; Smith VB; Smith LM; Sarvetnick N
    Front Immunol; 2021; 12():604157. PubMed ID: 33708202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody.
    Yamaguchi K; Mishima K; Ohmura H; Hanamura F; Ito M; Nakano M; Tsuchihashi K; Ota SI; Wada N; Uchi H; Ariyama H; Kusaba H; Niiro H; Akashi K; Baba E
    Cancer Sci; 2018 Oct; 109(10):3032-3042. PubMed ID: 30066977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Tim-1 and IL-10 Expression in Regulatory B Cell Subsets in Type 1 Diabetes.
    Liu Y; Chen Z; Qiu J; Chen H; Zhou Z
    Front Immunol; 2021; 12():773896. PubMed ID: 35754999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.